ErbB signaling and cell cycle pathways associated with trastuzumab deruxtecan resistance in HER2-positive metastatic breast cancer: a case report.
Saved in:
| Title: | ErbB signaling and cell cycle pathways associated with trastuzumab deruxtecan resistance in HER2-positive metastatic breast cancer: a case report. |
|---|---|
| Authors: | Gao HF; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China., Lin YY; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.; School of Medicine, South China University of Technology, Guangzhou, China., Lv XZ; Burning Rock Biotech Ltd., Guangzhou, China., Li H; Biomedical Laboratory, Jingke BioTech Group, Guangzhou, China., Xu FP; Department of Pathology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China., Wang K; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. |
| Source: | AME case reports [AME Case Rep] 2025 Sep 29; Vol. 9, pp. 118. Date of Electronic Publication: 2025 Sep 29 (Print Publication: 2025). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: AME Publishing Company Country of Publication: China NLM ID: 101730832 Publication Model: eCollection Cited Medium: Internet ISSN: 2523-1995 (Electronic) Linking ISSN: 25231995 NLM ISO Abbreviation: AME Case Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2523-1995 |
|---|---|
| DOI: | 10.21037/acr-2025-118 |
